None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients will be included in the study- Applying criteria given by Shankar et al Fever , headache, signs of meningismus and other clinical presentations of meningitis lasted for more than 2 weeks. Typical cerebrospinal fluid (CSF) features including pleocytosis with more than 20 cells, lymphocytes greater than 60%, protein greater than 100mg% and glucose level less than 60% of the corresponding blood glucose level. Sterile bacterial and fungal culture
Exclusion criteria
Exclusion criteria: 1. Patients who have already taken ATT for more than 3 months. 2. Patients with cryptococcal meningitis 3. Any other cause for meningitis detected during the course of therapy. 4. If the consent is not available or problematic follow up is anticipated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glasgow coma scale,disability as per modified barthal's index,MRC staging of TBM.Timepoint: 0,1,3 AND 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India